Fibulin-3 is a novel TGF-β pathway inhibitor in the breast cancer microenvironment.
about
Mechanisms of TGFβ-Induced Epithelial-Mesenchymal TransitionTamoxifen Action in ER-Negative Breast Cancer.Epidermal growth factor-containing fibulin-like extracellular matrix protein 1 expression and regulation in uterine leiomyoma.Exosome-mediated delivery of miR-9 induces cancer-associated fibroblast-like properties in human breast fibroblasts.Weaponizing human EGF-containing fibulin-like extracellular matrix protein 1 (EFEMP1) for 21st century cancer therapeutics.Stromal Modulators of TGF-β in Cancer.Fibulin-4 is associated with prognosis of endometrial cancer patients and inhibits cancer cell invasion and metastasis via Wnt/β-catenin signaling pathway.Agonists and Antagonists of TGF-β Family Ligands.Fibulin-6 regulates pro-fibrotic TGF-β responses in neonatal mouse ventricular cardiac fibroblasts.MicroRNA‑126 inhibits endothelial permeability and apoptosis in apolipoprotein E‑knockout mice fed a high‑fat dietIdentification of new regulators of embryonic patterning and morphogenesis in Xenopus gastrulae by RNA sequencing.Fibulin-3 promotes muscle-invasive bladder cancer.Plasma Fibulin-3 as a Potential Biomarker for Patients with Asbestos-Related Diseases in the Han Population.A genome-wide association study identifies a susceptibility locus for biliary atresia on 2p16.1 within the gene EFEMP1Extracellular Interactions between Fibulins and Transforming Growth Factor (TGF)-β in Physiological and Pathological Conditions
P2860
Q26745545-D63CAF2D-3C21-42A4-B865-698B5237A009Q36688302-E86AC60C-881F-400C-BAD5-AAD9674B6D27Q36794310-482D341F-CBA2-4B07-990B-32493581B9AEQ37151539-CE4D4F37-D8A7-4B66-9E3E-27C96590A86FQ37298184-3A4FC75F-28EA-42B0-BBD1-4FCB9A18BD17Q37628179-F7381D32-C518-4935-8C6E-468F51C98111Q37745906-DCADE9F4-DAA8-4A30-915B-CB4F31015753Q38896053-57F62189-D7DF-427E-A166-88CC2C8D95CDQ40328847-41239CA1-3865-4B7D-B2C5-F8D7C1EEDE4EQ42546572-373A9EEC-A6D9-445B-9067-BD2DF8B352CDQ42773661-68BFECAF-0094-43D2-8963-231BFB5985E3Q42776532-5A779777-B286-4359-8CAB-D4BE0DA07F00Q45824718-411C7548-CF70-4EAC-833A-40A66079A003Q57112027-56873C9C-60CA-42FD-A854-DBDF44D8A18FQ58730304-8FF7BCE0-9865-42F5-B2D3-0C9A55AE1F2D
P2860
Fibulin-3 is a novel TGF-β pathway inhibitor in the breast cancer microenvironment.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Fibulin-3 is a novel TGF-β pathway inhibitor in the breast cancer microenvironment.
@ast
Fibulin-3 is a novel TGF-β pathway inhibitor in the breast cancer microenvironment.
@en
type
label
Fibulin-3 is a novel TGF-β pathway inhibitor in the breast cancer microenvironment.
@ast
Fibulin-3 is a novel TGF-β pathway inhibitor in the breast cancer microenvironment.
@en
prefLabel
Fibulin-3 is a novel TGF-β pathway inhibitor in the breast cancer microenvironment.
@ast
Fibulin-3 is a novel TGF-β pathway inhibitor in the breast cancer microenvironment.
@en
P2093
P2860
P356
P1433
P1476
Fibulin-3 is a novel TGF-β pathway inhibitor in the breast cancer microenvironment.
@en
P2093
P2860
P2888
P304
P356
10.1038/ONC.2015.13
P407
P577
2015-03-30T00:00:00Z